Synthetic peptide, and cosmetic composition or pharmaceutical composition and application thereof
US-2024352069-A1 · Oct 24, 2024 · US
Nanoemulsion therapeutic compositions and methods of using the same
US8962026B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8962026-B2 |
| Application number | US-56757109-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 25, 2009 |
| Priority date | Sep 26, 2008 |
| Publication date | Feb 24, 2015 |
| Grant date | Feb 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a Burkholderia antigen) that generate an effective immune response (e.g., against a bacterial species of the genus Burkholderia ) in a subject administered the immunogenic composition. Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.
First claim
Opening claim text (preview).
We claim: 1. A method of treating inflammation and edema associated with a burn wound, comprising: A) providing i) a subject harboring a burn wound; and ii) a composition comprising a nanoemulsion, wherein said nanoemulsion comprises: 1. 30-90%, 60-80%, or 60-70% by volume oil; 2. 3-15% by volume solvent; wherein said solvent is selected from the group consisting of ethanol and glycerol; 3. 0.05-10.0% by volume non-ionic surfactant and 0.001-5.0% by volume cationic surf…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K9/1075Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K31/198Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8962026B2 cover?
- The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a Burkholderia …
- Who is the assignee on this patent?
- Baker Jr James R, Hemmila Mark R, Wang Stewart C, and 8 more
- What technology area does this patent fall under?
- Primary CPC classification A61K9/1075. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).